https://www.politico.com/news/2023/01/09/pepsi-coke-soda-federal-probe-00077126
Precipio And Cardinal Health Sign Distribution Agreement For Its HemeScreen Portfolio Of Molecular Assays For Cancer
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products. Under the agreement,